Summary.-DNA/cell distributions were recorded by automated cytofluorometry ( = pulse cytophotometry) in bone-marrow aspirates of leukaemia and lymphosarcoma patients subjected to chemotherapy. In most cases, early perturbations in DNA/cell histographs were observed, characteristically reflecting the known mode of action of the drugs. These changes in general preceded the clinical observation of drug response.
( = pulse cytophotometry) in bone-marrow aspirates of leukaemia and lymphosarcoma patients subjected to chemotherapy. In most cases, early perturbations in DNA/cell histographs were observed, characteristically reflecting the known mode of action of the drugs. These changes in general preceded the clinical observation of drug response.
In a series of 23 measurements in 19 patients, a positive correlation between early cytophotometric changes and clinical effects of chemotherapy was observed in 17 patients. Five patients were negative for both cytophotometric and clinical reactions and one patient was probably false-positive. The validity of the assay for early detection of drug resistance in acute leukaemia and related diseases is discussed.
PULSE CYTOPHOTOMETERS can measure the DNA content of single cells in suspension stained by specific, fluorescent dyes (Crissman, Mtillaney and Steiiikamp, 1975; Gohde, 1973) . DNA/cell distributions of high statistical reliability can be obtained within 2 h following sampling of cells. The main advantage of pulse cytophotometry over radioautography resides in the speed and simplicity with which the information is obtained. Moreover, DNA/ cell distributions yield direct information regarding the frequency of cells outside the S compartment even when the radioautographic technique is rendered blind by drugs which interfere with DNA synthesis. The technique has been used to coirrelate proliferative activity and remission expectation in adult AML (Hillen, 1aanen and Wessels, 1975) and to (letect circulating tumour cells in the peripheral blood of lymphoma patients (Cleton et al., 1975) .
Pulse cytophotometry might find clinical application in monitoring individual cytokinetic responses during chemotherapy.
The information thus obtained could be of prognostic value for the clinical effectiveness of the drug used and eventually result in the timely adjustment of the chemotherapeutic strategy (Haanen, 1975) .
In the present study, we investigated firstly, whether DNA/cell distributions from bone-marrow aspirates, recorded in the early phase of cytostatic treatment, displayed perturbations representative of the known action of a variety of drugs. Secondly, in a number of cases the presence or absence of characteristic changes was correlated with the clinical evaluation of drug effectiveness. (Berkhan, 1975 
RESULTS

Prednisone and vincristine
The effect of treatment with prednisone and vincristine was studied in 7 patients with ALL, 2 patients with leukaemic transformed lymphosarcoma, 1 patient with neuroblastoma infiltrated into the bone-marrow and 1 patient with monocytic leukaemia. Samples were investigated at several times after the start of treatment but consistent changes were first observed after 24 h. All except 1 patient reacted by depression of the number of S-phase cells, ranging from a 2-fold to a 10-fold reduction. The response was most evident in patients showing a high number of S-phase cells at the start of therapy (Fig. 1) . A decrease in the fraction of S-phase cells reflects the known inhibition by corticosteroids of the transition from G1 to S phase (Mauer, 1975) and corroborates the results of other workers (Hillen et al., 1975) .
Accumulation of cells with tetraploid DNA content, due to the mitostatic effect of vincristine, was observed only in the adult patients and in a case of childhood ALL in remission. In the latter patient, mainly erythroblasts blocked in mitosis were observed in the smears. Apparently, either tumour blasts in childhood leukaemia were lysed by the corticosteroids before or during accumulation in metaphase, or these cells had become (Lampkin, McWilliams and Mauer, 1971a ) and pulse cytophotometry (Buchner et al., 1975) have been reported. A detailed account of the effect of Ara-C in human patients and in model systems will be presented elsewhere.
L-asparaginase
A young patient (A.C.) in relapse of ALL was studied during chemotherapy with L-asparaginase. In the DNA/cell histographs (Fig. 3) Fig. 3 ). Three days after therapy, a drastic drop in S and G2-phase tumour cells was observed and the proportion of normal cells had almost doubled without a detectable reduction in G2-phase cells. These changes are compatible with the cell lysis and the block in G1 phase specifically induced in tumour cells by L-asparaginase (Saunders, 1972) . Similar changes will probably be found in samples taken within less than 3 days. (Fig. 4) . A considerable degree of cell death was indicated by the appearance of signals in the first channels of the histograph and by broadening of the G1 peak. This type of response could be duplicated by x-irradiation in systems in vitro and confirms the inhibition of DNA synthesis by alkylating drugs (Lampkin, Nagao and Mauer, 12 1971b). In patient M.E., the initial number of S-phase cells amounted to 15% indicating a population of actively proliferating tumour cells. The shaded area in Fig. 4 (Tobey, 1972; Strijckmansetal., 1973) . In patient Y.B., the proportion of S-phase cells dropped from 300o to 8% and that of cells in G2 increased from 90% to 15 % in 24 h. In patient T.I., S-phase cells were reduced from 6% to 3% and (4 phase cells had increased from 200 to 10% in the same period. After 48 h the corresponding figures for patient H.P.
were from 22% to 8% and from 2% to 110% for S and G2-phase cells respectively. Patient M.A. responded to adriamycin in the first cycle of treatment by a fourfold reduction in S-phase cells. However, in the second cycle no cytophotometric nor clinical response to adriamycin followed by vincristine was noted. Similarly patient T.E., who failed to respond to chemotherapy, did not show significant changes in the DNA/cell distributions.
Pulse cytophotometric changes and clinical effects
In the phase content during therapy with Ara-C has been observed by others as well (Lampkin et al., 1971b; Buchner et al., 1975) it has not been found by IHillen et al. (1975) . This discrepancy may be explained by differences in the preparative techniques, particularly the pretreatment with pepsin, which eliminates damaged cells (Berkhan, 1972 (Fig. 4) . These agents are known to kill cells with delayed cell lysis, a property used to prepare feeding layers of irradiated cells and to inactivate cells with mitomycin for mixed lymphocyte cultures.
The effect of most drugs in first case leukaemia is well documented and can be monitored over time by routine methods, for instance in the case of ALL. Therefore a correlation between pulse cytophotometric changes and clinical response in primary ALL is largely confirmative and of little practical value. However, this may not hold in all cases, for example in the use of L-asparaginase, or in cases of relapse when a clinical response is less likely to occur. The early suggestion by pulse cytophotometry of drug insensitivity in 5 patients indicates that it is basically possible to develop drug sensitivity tests using this technique.
In fact the pulse cytophotometric assay meets a number of conditions which a successful predictive test would have to fulfil. The assay is simple and rapid and does not cause unacceptable discomfort to most of the patients. Moreover, unlike in vitro cytotoxicity tests, the assay is maximally representative for factors in situ which affect local concentrations of active drug metabolites and cytokinetic reactions.
It is not overlooked that these studies had to be limited to patients whose bonemarrow contained mainly leukaemic blasts. Pulse cytophotometric studies are invalid for mixed populations of normal and tumour cells, except in the case of tumour cell aneuploidy (cf. Fig. 3 ). However, cell separation techniques are in rapid evolution and concentration of proliferating tumour blasts from complex populations has been successfully achieved by density gradient separation techniques (Cleton et al., 1975) .
While admittedly preliminary, the results suggest that the pulse cytophotometric assay may contribute to the design of an optimal chemotherapeutic strategy, particularly in cases of relapse from acute leukaemia and in childhood lymphoma.
The 
